Zobrazeno 1 - 10
of 14
pro vyhledávání: '"MESH: Radiotherapy, Conformal"'
Radiothérapie avec modulation d’intensité préopératoire des cancers rectaux : intérêt et application
Publikováno v:
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2020, 24 (4), pp.345-353. ⟨10.1016/j.canrad.2019.11.005⟩
Cancer/Radiothérapie
Cancer/Radiothérapie, Elsevier Masson, 2020, 24 (4), pp.345-353. ⟨10.1016/j.canrad.2019.11.005⟩
Cancer Radiothérapie, Elsevier Masson, 2020, 24 (4), pp.345-353. ⟨10.1016/j.canrad.2019.11.005⟩
Cancer/Radiothérapie
Cancer/Radiothérapie, Elsevier Masson, 2020, 24 (4), pp.345-353. ⟨10.1016/j.canrad.2019.11.005⟩
International audience; Preoperative radiotherapy boosted by chemotherapy is a recommended treatment in locally advanced rectal cancers. This treatment is delivered by three dimensional conformal irradiation, which is usually well tolerated but can i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::173aa48fdb39b1b6b5e9f0e17c3a2246
https://hal.archives-ouvertes.fr/hal-03052633
https://hal.archives-ouvertes.fr/hal-03052633
Autor:
S. Simeon, Norbert Ailleres, C. Kerr, D. Azria, J. Molinier, Pascal Fenoglietto, M. Charissoux
Publikováno v:
Journal of Applied Clinical Medical Physics
Journal of Applied Clinical Medical Physics, American Association of Physicists in Medicine, 2016, 17 (1), pp.92-101. ⟨10.1120/jacmp.v17i1.5677⟩
Journal of Applied Clinical Medical Physics, WILEY, 2016, 17 (1), pp.92-101. ⟨10.1120/jacmp.v17i1.5677⟩
Journal of Applied Clinical Medical Physics, American Association of Physicists in Medicine, 2016, 17 (1), pp.92-101. ⟨10.1120/jacmp.v17i1.5677⟩
Journal of Applied Clinical Medical Physics, WILEY, 2016, 17 (1), pp.92-101. ⟨10.1120/jacmp.v17i1.5677⟩
International audience; The aim was to analyze arc therapy techniques according to the number and position of the brain lesions reported by comparing dynamic noncoplanar conformal arcs (DCA), two coplanar full arcs (RAC) with volumetric-modulated arc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc0e54156787f561655d4deef4ec8cce
https://hal.umontpellier.fr/hal-02297779
https://hal.umontpellier.fr/hal-02297779
Publikováno v:
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (6-7), pp.440-444. ⟨10.1016/j.canrad.2011.05.006⟩
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (6-7), pp.440-444. 〈10.1016/j.canrad.2011.05.006〉
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (6-7), pp.440-444. ⟨10.1016/j.canrad.2011.05.006⟩
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (6-7), pp.440-444. 〈10.1016/j.canrad.2011.05.006〉
International audience; Protracted preoperative radiochemotherapy with a 5-FU-based scheme, or a short course of preoperative radiotherapy without chemotherapy, are the standard neoadjuvant treatments for resectable stage II-III rectal cancer. Local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fa711816b7701742d8660cdadb87d94d
https://hal.archives-ouvertes.fr/hal-00719140
https://hal.archives-ouvertes.fr/hal-00719140
Autor:
Barhoumi , M., Mornex , F., Bonnetain , Franck, Rougier , P., Mariette , C., Bouché , O., Bosset , J.-F., Aparicio , T., Mineur , L., Azzedine , A., Hammel , P., Butel , J., Stremsdoerfer , N., Maingon , P., Bedenne , L., Chauffert , B.
Publikováno v:
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (3), pp.182-191
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (3), pp.182-191. ⟨10.1016/j.canrad.2010.10.001⟩
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (3), pp.182-191. 〈10.1016/j.canrad.2010.10.001〉
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (3), pp.182-191
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (3), pp.182-191. ⟨10.1016/j.canrad.2010.10.001⟩
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (3), pp.182-191. 〈10.1016/j.canrad.2010.10.001〉
International audience; PURPOSE: To compare chemoradiation with systemic chemotherapy to chemotherapy alone in locally advanced pancreatic cancer. PATIENTS AND METHODS: One hundred and nineteen patients with locally advanced pancreatic cancer, with W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::aaedef00934511e748102fedb2d1dc14
https://hal.archives-ouvertes.fr/hal-00596035
https://hal.archives-ouvertes.fr/hal-00596035
Autor:
Bolla , Michel, De Reijke , Theodorus M, Van Tienhoven , Geertjan, Van Den Bergh , Alphonsus C M, Oddens , Jorg, Poortmans , Philip M P, Gez , Eliahu, Kil , Paul, Akdas , Atif, Soete , Guy, Kariakine , Oleg, Van Der Steen-Banasik , Elsbietha M, Musat , Elena, Piérart , Marianne, Mauer , Murielle E, Collette , Laurence, Renseigné , Non, Bosset , Jean-François
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2009, 360 (24), pp.2516-2527. 〈10.1056/NEJMoa0810095〉
New England Journal of Medicine, Massachusetts Medical Society, 2009, 360 (24), pp.2516-2527. ⟨10.1056/NEJMoa0810095⟩
New England Journal of Medicine, 360(24), 2516-2527. MASSACHUSETTS MEDICAL SOC
New England journal of medicine, 360(24), 2516-2527. Massachussetts Medical Society
New England Journal of Medicine, Massachusetts Medical Society, 2009, 360 (24), pp.2516-2527. 〈10.1056/NEJMoa0810095〉
New England Journal of Medicine, Massachusetts Medical Society, 2009, 360 (24), pp.2516-2527. ⟨10.1056/NEJMoa0810095⟩
New England Journal of Medicine, 360(24), 2516-2527. MASSACHUSETTS MEDICAL SOC
New England journal of medicine, 360(24), 2516-2527. Massachussetts Medical Society
International audience; BACKGROUND: The combination of radiotherapy plus long-term medical suppression of androgens (> or = 2 years) improves overall survival in patients with locally advanced prostate cancer. We compared the use of radiotherapy plus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d32d2531b6803c4526344e7fb938e50
https://hal.archives-ouvertes.fr/hal-00492521
https://hal.archives-ouvertes.fr/hal-00492521
Autor:
F. Lorchel, Pierre Aletti, Alain Noel, Y. Perrot, P. Courvoisier, J.F. Bosset, J.L. Dumas, Didier Wolf
Publikováno v:
Physica Medica
Physica Medica, Elsevier, 2007, 23 (1), pp.16-24. 〈10.1016/j.ejmp.2006.12.003〉
Physica Medica, Elsevier, 2007, 23 (1), pp.16-24. ⟨10.1016/j.ejmp.2006.12.003⟩
Physica Medica, 2007, 23 (1), pp.16-24. ⟨10.1016/j.ejmp.2006.12.003⟩
Physica Medica, Elsevier, 2007, 23, pp.16-24
Physica Medica, Elsevier, 2007, 23 (1), pp.16-24. 〈10.1016/j.ejmp.2006.12.003〉
Physica Medica, Elsevier, 2007, 23 (1), pp.16-24. ⟨10.1016/j.ejmp.2006.12.003⟩
Physica Medica, 2007, 23 (1), pp.16-24. ⟨10.1016/j.ejmp.2006.12.003⟩
Physica Medica, Elsevier, 2007, 23, pp.16-24
International audience; BACKGROUND AND PURPOSE: The goal of our study was to quantify the limits of the EUD models for use in score functions in inverse planning software, and for clinical application. MATERIALS AND METHODS: We focused on oesophagus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e7118d6e7b82fe98a2e3c2186d7f79a
https://hal.archives-ouvertes.fr/hal-00492613
https://hal.archives-ouvertes.fr/hal-00492613
Publikováno v:
Radiotherapy and Oncology
Radiotherapy and Oncology, Elsevier, 2006, 80 (3), pp.327-332. ⟨10.1016/j.radonc.2006.08.003⟩
Radiotherapy and Oncology, Elsevier, 2006, 80 (3), pp.327-332. 〈10.1016/j.radonc.2006.08.003〉
Radiotherapy and Oncology, Elsevier, 2006, 80 (3), pp.327-332. ⟨10.1016/j.radonc.2006.08.003⟩
Radiotherapy and Oncology, Elsevier, 2006, 80 (3), pp.327-332. 〈10.1016/j.radonc.2006.08.003〉
International audience; BACKGROUND AND PURPOSE: To evaluate esophageal tumor and OAR movement during the respiratory cycle in order to obtain optimal values for ITV and PRV. To correlate tumor motion with chest wall displacement - information of valu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f81dae3e48682d72510faf1f99eed0d3
https://hal.archives-ouvertes.fr/hal-00492889
https://hal.archives-ouvertes.fr/hal-00492889
Autor:
Boehmer , Dirk, Maingon , Philippe, Poortmans , Philip, Baron , Marie-Hélène, Miralbell , Raymond, Remouchamps , Vincent, Jacoulet , Pascale, Bossi , Alberto, Bolla , Michel, Renseigné , Non
Publikováno v:
Radiotherapy and Oncology
Radiotherapy and Oncology, Elsevier, 2006, 79 (3), pp.259-269. 〈10.1016/j.radonc.2006.05.012〉
Radiotherapy and Oncology, Elsevier, 2006, 79 (3), pp.259-269. ⟨10.1016/j.radonc.2006.05.012⟩
Radiotherapy and Oncology, Elsevier, 2006, 79 (3), pp.259-269. 〈10.1016/j.radonc.2006.05.012〉
Radiotherapy and Oncology, Elsevier, 2006, 79 (3), pp.259-269. ⟨10.1016/j.radonc.2006.05.012⟩
Background and purposes: The, appropriate application of 3-D conformal radiotherapy, intensity modulated radiotherapy or image guided radiotherapy for patients undergoing radiotherapy for prostate cancer requires a standardisation of target delineati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::684f045073cdf84f4dad87cf18a0c900
https://hal.archives-ouvertes.fr/hal-00492885
https://hal.archives-ouvertes.fr/hal-00492885
Autor:
Nidal M. Albarghach, Jean-Philippe Metges, Laurent Corcos, Florent Tixier, Olivier Pradier, Mathieu Hatt, Catherine Cheze Le Rest, Dimitris Visvikis
Publikováno v:
Journal of Nuclear Medicine
Journal of Nuclear Medicine, 2011, 52 (3), pp.369-78. ⟨10.2967/jnumed.110.082404⟩
Journal of Nuclear Medicine, Society of Nuclear Medicine, 2011, 52 (3), pp.369-78. ⟨10.2967/jnumed.110.082404⟩
Journal of Nuclear Medicine, 2011, 52 (3), pp.369-78. ⟨10.2967/jnumed.110.082404⟩
Journal of Nuclear Medicine, Society of Nuclear Medicine, 2011, 52 (3), pp.369-78. ⟨10.2967/jnumed.110.082404⟩
International audience; UNLABELLED: (18)F-FDG PET is often used in clinical routine for diagnosis, staging, and response to therapy assessment or prediction. The standardized uptake value (SUV) in the primary or regional area is the most common quant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b02b03c2416cf68ed5127e7eee7b7211
https://www.hal.inserm.fr/inserm-00574272/file/inserm-00574272_edited.pdf
https://www.hal.inserm.fr/inserm-00574272/file/inserm-00574272_edited.pdf
Autor:
Merle, P., Mornex, F.
Publikováno v:
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (1), pp.69-71. ⟨10.1016/j.canrad.2010.11.001⟩
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (1), pp.69-71. ⟨10.1016/j.canrad.2010.11.001⟩
International audience; Hepatocellular carcinoma is a poor prognosis tumour. The potential curative therapeutic options are orthotopic liver transplantation, surgical resection and radiofrequency ablation. Unfortunately, only a minority of patients (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::deccc9b964a51439a34bb7e291b5cb43
https://hal.archives-ouvertes.fr/hal-00851388
https://hal.archives-ouvertes.fr/hal-00851388